Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

439

Participants

Timeline

Start Date

February 26, 2015

Primary Completion Date

January 5, 2017

Study Completion Date

January 6, 2017

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Anlotinib

Basic dosage, take once when limosis in the morning. If patients cannot suffer from AEs, they can get declined dosage.

DRUG

Placebo

Basic dosage, take once when limosis in the morning.

Trial Locations (40)

200000

Chest hospital affiliated to Shanghai jiaotong university, Shanghai

300600

20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital ., Tianjin

Unknown

Beijing Friendship Hospital, Capital Medical University, Beijing

Capital Medical University, Beijing Chest Hospital, Beijing

Chinese Academy of Medical Sciences Cancer Hospital, Beijing

Peking Union Medical College Hospital, Beijing

Chongqing Cancer Hospital, Chongqing

Xinqiao Hospital, Chongqing

Fujian Province Tumor Hospital, Fuzhou

Gansu Province Tumor Hospital, Lanzhou

Gansu Provincial People 's Hospital, Lanzhou

Lanzhou Military General Hospital, Lanzhou

First Affiliated Hospital of Guangzhou Medical University, Guangzhou

First Affiliated Hospital of Shantou University Medical College, Shantou

Fourth Hospital of Hebei Medical University, Shijiazhuang

Harbin medical university affiliated tumor hospita, Harbin

Henan Province Tumor Hospital, Luoyan

Hunan Province Tumor Hospital, Changsha

Xiangya Hospital Central South University, Changsha

Lianyungang First People 's Hospital, Lianyungang

Xuzhou Medical College Hospital, Xuzhou

Jiangxi Province Tumor Hospital, Nanchang

Second Affiliated Hospital of Nanchang University, Nanchang

Jilin Province Tumor Hospital, Changchun

Liaoning Provincial Tumor Hospital, Shenyang

Qilu Hospital,Shandong University, Jinan

Shandong Province Tumor Hospital, Jinan

Linyi City Tumor Hospita, Linyi

Cancer Hospital of Fudan University, Shanghai

Shanghai Changhai Hospital, Shanghai

Xinhua hospital affiliated to Shanghai jiaotong university, Shanghai

First Affiliated Hospital of Xi'an Jiaotong University, Xian

Tang Du Hospital, Xian

West China Hospital , Sichuan University, Chengdu

Sichuan Cancer Hospital, Chongqing

Tianjin Medical University General Hospital, Tianjin

Yunnan Province Tumor Hospital, Kunming

The First Affiliated Hospital of Zhejiang University, Hangzhou

The Second Affiliated Hospital of Zhejiang University, Hangzhou

Zhejiang Province Tumor Hospital, Hangzhou

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY